MUC1 expression in thymic epithelial tumors: MUC1 may be useful marker as differential diagnosis between type B3 thymoma and thymic carcinoma

Virchows Archiv

Volumn 458, Issue 5, 2011, Pages 615-620

  Kaira, Kyoichi ^a   Murakami, Haruyasu ^a   Serizawa, Masakuni ^a   Koh, Yasuhiro ^a   Abe, Masato ^a   Ohde, Yasuhisa ^a   Takahashi, Toshiaki ^a   Kondo, Haruhiko ^a   Nakajima, Takashi ^a   Yamamoto, Nobuyuki ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

Author keywords

MUC1; Prognosis; Thymic carcinoma; Thymic epithelial tumor; Type B3 thymoma

Indexed keywords

CD34 ANTIGEN; MUCIN 1; PROTEIN P53; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; DIFFERENTIAL DIAGNOSIS; EPITHELIUM TUMOR; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; THYMIC EPITHELIAL TUMOR; THYMOMA; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUCIN-1; NEOPLASMS, GLANDULAR AND EPITHELIAL; THYMOMA; THYMUS NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79956195048     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-011-1041-x     Document Type: Article

References (21)

1. Engels EA, Pfeiffer RW (2003) Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer 105:546-551 (Pubitemid 36578561)
2. Rosai J, Sobin LH (1999) Histological typing of tumours of the thymus, International histological classification of tumours, 2nd edn. Springer, New York, pp 1-59
3. Travis WD, Brambillia E, Muller-Hermelink HK (2004) WHO classification of tumors. Pathology and genetics of tumors of the lung, pleura, thymus and heart. IARC Press, Lyon
4. Gendler SJ, Lancaster CA, Taylor-Papadimitriou J et al (1990) Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J Biol Chem 265:15286-15293
5. Schroeder JA, Masril AA, Adriance MC et al (2004) MUC1 overexpression results in mammary gland tumorigenesis and prolonged alveolar differentiation. Oncogene 23:5739-5747 (Pubitemid 39093019)
6. Nagai S, Takenaka K, Sonobe M et al (2006) A novel classification of MUC1 expression is correlated with tumor differentiation and postoperative prognosis in non-small cell lung cancer. J Thorac Oncol 1:46-51 (Pubitemid 47164020)
7. Broadbent R, Thynne G, McKenzie IFC (1997) Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein. J Clin Invest 100:2783-2792 (Pubitemid 28007547)
8. Woenckhaus M, Merk J, Stoehr R et al (2008) Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer. Hum Pathol 39:126-136
9. Masaoka A, Monden Y, Nakahara K et al (1981) Follow-up study of thymomas with special reference to their clinical stages. Cancer 48:2485-2492 (Pubitemid 12228012)
10. 18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors. J Clin Oncol 28:3746-3753
11. Utsunomiya T, Yonezawa S, Sakamoto H et al (1998) Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Clin Cancer Res 4:2605-2614 (Pubitemid 28523486)
12. Hinoda Y, Ikematsu Y, Horinouchi M et al (2003) Increased expression of MUC1 in advanced pancreatic cancer. J Gastroenterol 38:1162-1166 (Pubitemid 38128828)
13. Tamada S, Goto M, Nomoto M et al (2002) Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: its relationship with tumor progression and prognosis. Pathol Int 52:713-723 (Pubitemid 35472026)
14. Kawamoto T, Shoda J, Miyahara N et al (2004) Expression of MUC1 recognized by a monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of carcinoma of the gallbladder. Clin Exp Metastasis 21:353-362
15. Feng H, Ghazizadeh M, Konishi H et al (2002) Expression of MUC1 and MUC2 mucin gene products in human ovarian carcinomas. Jpn J Clin Oncol 32:525-529 (Pubitemid 43102758)
16. Sivridis E, Giatromanolaki A, Koukourakis MI et al (2002) Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic relevance. Histopathology 40:92-100 (Pubitemid 34107387)
17. Baldus SE, Monig SP, Huxel S et al (2004) MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis. Clin Cancer Res 10:2790-2796 (Pubitemid 38509157)
18. Kirschenbaum A, Itzkowitz SH, Wang JP et al (1999) MUC1 expression in prostate carcinoma: correlation with grade and stage. Mol Urol 3:163-168
19. Kojika M, Ishii G, Yoshida J et al (2010) Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker, GLUT1, in thymic epithelial neoplasms. Modern Pathol 22:1341-1350
20. Kontani K, Taguchi O, Ozaki Yet al (2003) Dendritic cell vaccine immunotherapy of cancer targeting MUC1 mucins. Int J Mol Med 12:493-502
21. Kufe DW (2009) Functional targeting of the MUC1 oncogene in human cancers. Cancer Biol Ther 8:1197-1203